Literature DB >> 2776895

Selective reduction in multiple gestations: pregnancy outcome after transvaginal and transabdominal needle-guided procedures.

J Shalev1, Y Frenkel, M Goldenberg, E Shalev, S Lipitz, G Barkai, L Nebel, S Mashiach.   

Abstract

Selective fetal reduction was performed in the first trimester of pregnancy in 20 women with multifetal gestations after ovulation induction with human menopausal gonadotropin (hMG). In 10 women (group A) reduction was performed transabdominally, and in 10 women (group B) the transvaginal approach was used. The transvaginal technique achieved penetration of several gestational sacs without withdrawing the needle from the uterus. Fetal termination using either procedure occurred with intrafetal injection of potassium chloride. Six (60%, group A) and eight (80%, group B) patients delivered healthy newborns. One patient (group B) is at 30 weeks' gestation. Four (40%, group A) and one (10%, group B) aborted 1 day to 8 weeks after the procedure (1 septic abortion, each group). Our results suggest that transvaginal fetal reduction offers a better outcome, with minimal complications, to patients referred for selective continuation of pregnancy.

Entities:  

Keywords:  Asia; Developed Countries; Examinations And Diagnoses; Israel; Mediterranean Countries; Pregnancy; Pregnancy Outcomes; Pregnancy, First Trimester; Pregnancy, Multiple--changes; Reproduction; Ultrasonics; Western Asia

Mesh:

Year:  1989        PMID: 2776895     DOI: 10.1016/s0015-0282(16)60910-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Embryo reduction: our experience.

Authors:  Pankaj Talwar; R K Sharma; K Sandeep; Shashi Sareen; B S Duggal
Journal:  Med J Armed Forces India       Date:  2011-08-07

Review 2.  Reduction of the number of fetuses for women with a multiple pregnancy.

Authors:  Jodie M Dodd; Therese Dowswell; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2015-11-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.